Uncovering Phase Three Clinical Data Results for MBK-01 in Primary & Recurrent C.Diff Infection
Time: 1:30 pm
day: Day 2 Track A AM
Details:
- Sharing clinical data from most advanced product
- Exploring regulatory challenges
- Navigating early pricing and reimbursement considerations
